T-Cell PET Imaging With [18F]F-AraG in Lung Cancer

NCT03311672 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Low Accrual

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: [18F]F-Ara-G
DRUG: Pembrolizumab
RADIATION: PET/CT scan

Sponsor

University of California, San Francisco

Collaborators

[object Object]